Understanding the anti-tumour immune response to radionuclide therapy using PSMA targeting radiopharmaceuticals in a prostate cancer model
<p>The ability of external beam radiation (EBRT) to modulate the tumour immune microenvironment is becoming increasingly well understood, leading to the development of combinatorial EBRT and immunotherapeutic combinations to improve patient responses. Despite this, there is very limited unders...
Hlavní autor: | Anderson, R |
---|---|
Další autoři: | Vallis, K |
Médium: | Diplomová práce |
Jazyk: | English |
Vydáno: |
2021
|
Témata: |
Podobné jednotky
-
Recent Progress of Functionalized PSMA in Radionuclide Targeted Therapy for Prostate Cancer
Autor: REN Ya'nan, a další
Vydáno: (2020-12-01) -
Lead-212 Radiopharmaceuticals for Receptor-Targeted Radionuclide Therapy
Autor: Solmaz Mojarad-Jabali, a další
Vydáno: (2025-01-01) -
Radiopharmaceuticals: From Molecular Imaging to Targeted Radionuclide Therapy
Autor: P. August Schubiger, a další
Vydáno: (2004-10-01) -
Precision strikes: PSMA-targeted radionuclide therapy in prostate cancer – a narrative review
Autor: Paweł Szponar, a další
Vydáno: (2023-11-01) -
Can PSMA-Targeting Radiopharmaceuticals Be Useful for Detecting Hepatocellular Carcinoma Using Positron Emission Tomography? An Updated Systematic Review and Meta-Analysis
Autor: Alessio Rizzo, a další
Vydáno: (2022-11-01)